JVMSX | TRMCX | JVMSX / TRMCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 13 years | 28 years | - |
Gain YTD | 12.734 | 6.320 | 201% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 23.4B | 16.1B | 145% |
Annual Yield % from dividends | 0.52 | 0.97 | 54% |
Returns for 1 year | 10.70 | 8.12 | 132% |
Returns for 3 years | 16.81 | 4.16 | 404% |
Returns for 5 years | 40.17 | 23.33 | 172% |
Returns for 10 years | 56.91 | 23.09 | 246% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PJP | 84.59 | 0.76 | +0.91% |
Invesco Pharmaceuticals ETF | |||
UST | 42.18 | 0.05 | +0.12% |
ProShares Ultra 7-10 Year Treasury | |||
EMXF | 38.25 | -0.19 | -0.49% |
iShares ESG Advanced MSCI EM ETF | |||
FYX | 105.80 | -0.94 | -0.88% |
First Trust Small Cap Core AlphaDEX® ETF | |||
EMXC | 57.03 | -0.58 | -1.01% |
iShares MSCI Emerging Mkts ex China ETF |